PHARMA INVESTING NEWS, INC.

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

18 filing records in this dataset, filed from 2011-05-17 to 2014-12-22. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

See all insider transactions

Latest quarter

Revenue

5 thousand USD

2015 Q3 · USD

Exact inputs and evidence

Operating margin

-127,063.3%

2015 Q3 · %

Exact inputs and evidence
  • Operating Income: -6353165 USD Source
  • Revenue: 5000 USD Source

Operating cash flow

198 thousand USD

2015 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -180625 USD Source
  • Operating Cash Flow: -378401 USD Source

Free cash flow

197 thousand USD

2015 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -180625 USD Source
  • Operating Cash Flow: -378401 USD Source
  • Capital Expenditure: 6348 USD Source
  • Capital Expenditure: 5515 USD Source
Cash and cash equivalents
23 USD Source
Exact value

23 USD

Long-term debt including current maturities
Not available
Shares outstanding
28.8 million shares Source
Exact value

28831154 shares

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2014-12-22.

Financial data available through: 2013-01-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2013-01-31
  • Operating income: 2 of 11 periods available· newest 2013-01-31
  • Net income: 2 of 11 periods available· newest 2013-01-31
  • Operating cash flow: 2 of 11 periods available· newest 2013-01-31
  • capital expenditure: No compatible figures in this window
  • Total assets: 2 of 11 periods available· newest 2013-01-31
  • Total liabilities: 1 of 11 periods available· newest 2012-02-29
  • Current assets: 1 of 11 periods available· newest 2013-01-31
  • Current liabilities: 1 of 11 periods available· newest 2013-01-31
  • Cash and cash equivalents: 1 of 11 periods available· newest 2012-02-29
  • long term debt: No compatible figures in this window
  • Shares outstanding: 1 of 11 periods available· newest 2012-02-29

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2013 2012-02-01 – 2013-01-31

  • Revenue USD 182,621 100% of revenue
  • Operating costs Derived USD 326,806 179% of revenue
  • Operating income −USD 144,185 −79% of revenue
  • Tax, interest and other Derived −USD 75,747 −41% of revenue
  • Net income −USD 68,438 −37% of revenue

Cash

  • Operating cash flow USD 156,000 85% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2013 Not shown: operating income or net income is not reported.
  • 2013 Not shown: operating income or net income is not reported.
  • 2013 Operating loss: operating costs were 179% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2013 2011-02-09 – 2012-02-290 UnavailableUnavailableUnavailable-90697 Unavailable
Source
2013 2011-03-01 – 2012-02-290 84697 Derived -84697 0 Derived -84697 Unavailable
Source
2013 2012-02-01 – 2013-01-31182621 326806 Derived -144185 -75747 Derived -68438 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 182.6K 2013
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.197.2K147.9K98.6K49.3K0.02013
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2013Revenue182621

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2013Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -79% 2013
Net margin -37.5% 2013
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.6%-17%-39%-62%-85%2013
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2013Operating margin-79%
2013Net margin-37.5%
2013Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD 156K 2013
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.168.5K126.4K84.2K42.1K0.02013
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2013Operating cash flow156000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2013Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2013-01-31Liabilities / assetsNot reported

Current assets to current liabilities

Current assets divided by current liabilities.

0.39× 2013
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.42×0.32×0.21×0.11×0.00×2013
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2013Current assets / current liabilities0.39×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2013 2011-02-09 – 2012-02-29
−USD 90,697
Exact value

Exact value: -90697 USD

2011-02-09 – 2012-02-29: -90697 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 30,408
Exact value

Exact value: -30408 USD

2011-02-09 – 2012-02-29: -30408 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2013 2011-03-01 – 2012-02-29
−USD 84,697
Exact value

Exact value: -84697 USD

2011-03-01 – 2012-02-29: -84697 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 29,408
Exact value

Exact value: -29408 USD

2011-03-01 – 2012-02-29: -29408 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2013 2012-02-01 – 2013-01-31
−USD 68,438
Exact value

Exact value: -68438 USD

2012-02-01 – 2013-01-31: -68438 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 156,000
Exact value

Exact value: 156000 USD

2012-02-01 – 2013-01-31: 156000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

18 filings · 691 latest values · 691 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001520047, 1520047, edgar:1520047

Also known as Immunoclin Corp, PHARMA INVESTING NEWS, INC.